Exposure to antineoplastic drugs outside the hospital environment

Annals of Occupational Hygiene

Volumn 50, Issue 7, 2006, Pages 657-664

  Meijster, T ^a   Fransman, W ^a   Veldhof, R ^a   Kromhout, H ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antineoplastic drugs; Home care; Industrial laundry facilities; Nursing homes; Occupational exposure; Veterinary medicine

Indexed keywords

ANTINEOPLASTIC DRUGS; HOME CARE; INDUSTRIAL LAUNDRY FACILITIES; NURSING HOMES; OCCUPATIONAL EXPOSURE;

CONTAMINATION; DRUG PRODUCTS PLANTS; HEALTH RISKS; HOSPITALS; IDENTIFICATION (CONTROL SYSTEMS); PATIENT TREATMENT;

DRUG PRODUCTS;

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL;

AIR SAMPLING; CLEANING; CONTAMINATION; DRUG EXPOSURE; DRUG INDUSTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK POPULATION; HOME CARE; HUMAN; HUMAN TISSUE; INFORMATION RETRIEVAL; INHALATION; INTERVIEW; LAUNDRY; MAJOR CLINICAL STUDY; NETHERLANDS; NURSING HOME; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PATIENT CARE; PHARMACY; POTENTIOMETRY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; RISK FACTOR; UNIVERSITY; VETERINARY MEDICINE; WASTE MANAGEMENT; WORKPLACE;

ANTINEOPLASTIC AGENTS; ENVIRONMENTAL MONITORING; HOME CARE SERVICES; HUMANS; LAUNDERING; NETHERLANDS; NURSING HOMES; OCCUPATIONAL EXPOSURE; VETERINARY MEDICINE;

EID: 33749555066     PISSN: 00034878     EISSN: 14753162     Source Type: Journal    
DOI: 10.1093/annhyg/mel023     Document Type: Review

References (19)

1. Connor TH, Sessink PJM, Harrison BR et al. (2005) Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: Results of three studies. Am J Health Syst Pharm; 62: 475-84.
2. Del Gaudio D and Menonna-Quinn D. (1998) Chemotherapy. Potential occupational hazards. Am J Nurs; 98: 59-65.
3. Fransman W, Vermeulen R, Kromhout H. (2005) Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health; 78: 403-12.
4. Jeebhay M, Mbuli S, Uebel R. (1993) Assessment of exposure to chloramphenicol and azathioprine among workers in a South African pharmaceutical plant. Int Arch Occup Environ Health; 65: 119-22.
5. Kromhout H, Hoek F, Uitterhoeve R et al. (2000) Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg; 44: 551-60.
6. Meijster T, Fransman W, van Hemmen JJ et al. (2006) A probabilistic assessment of the impact of interventions on the exposure to antineoplastic agents of oncology nurses. Occup Environ Med published online 21 March 2006. doi:10.1136/oem.2005.022723.
7. Minoia C, Turci R, Sottani C et al. (1998) Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectrom; 12: 1485-93.
8. Pellicaan CH, Teske E. (1999) Risks of using cytostatic drugs in veterinary medical practice [article in Dutch]. Tijdschrift voor Diergeneeskunde; 124: 210-5.
9. Schmaus G, Schierl R, Funck S. (2002) Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health Syst Pharm; 59:956-61.
10. Selevan SG, Lindbohm ML, Hornung RW et al. (1985) A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med; 313: 1173-8.
11. Sessink PJM, Boer KA, Scheefhals APH et al. (1992) Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int Arch Occup Environ Health; 64: 105-12.
12. Sessink PJM, Scholtes MM, Anzion RBM et al. (1993) Determination of cyclofosfamide in urine by gas chromatographymass spectrometry. J Chromatogr B Biomed Appl; 616: 333-7.
13. Sessink PJ, Cerna M, Rossner P et al. (1994a) Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents. Mutat Res; 309: 193-9.
14. Sessink PJ, van de Kerkhof MC, Anzion RB et al. (1994b) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health; 49: 165-9.
15. Sessink PJ, Kroese ED, van Kranen HJ et al. (1995) Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int Arch Occup Environ Health; 67: 317-23.
16. Sessink PJ, Wittenhorst BC, Anzion RB et al. (1997) Exposure of pharmacy technicians to antineoplastic agents: reevaluation after additional protective measures. Arch Environ Health; 52: 240-4.
17. Sorsa M, Pyy L. (1990) Exposure assessment of workers in the production of cyclophosphamide. Pol J Occup Med Environ Health; 3: 185-9.
18. Sorsa M, Pyy L, Salomaa S et al. (1988) Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals. Mutat Res; 204: 465-79.
19. Stücker I, Caillard JF, Collin R et al. (1990) Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health; 16: 102-7.